Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Denali Therapeutics
Biotech
Takeda tears up Denali partnership, returning dementia asset
With DNL593 back in Denali's control, the biotech has no further collaborations ongoing with the Japanese pharma.
Darren Incorvaia
Apr 6, 2026 1:50pm
Fierce Pharma
FDA approves Denali's Hunter syndrome drug
Mar 25, 2026 2:50pm
Sanofi keeps mum on Denali pact after scrapping final RIPK1 drug
Jan 29, 2026 5:16am
Denali ph. 1 Pompe plans hit with clinical hold
Dec 4, 2025 11:52am
Royalty's $275M financing deal for Denali drug awaiting FDA nod
Dec 4, 2025 10:20am
Denali's Hunter syndrome drug latest to be hit by FDA delay
Oct 14, 2025 8:09am
